B.A. Payer

2.1k citations

42 papers · 1.7k · h-index 22

Impact in

Hepatology top 0.5%
- Liver Disease and Transplantation
- Hepatitis C virus research
- Hepatitis Viruses Studies and Epidemiology
- Hepatocellular Carcinoma Treatment and Prognosis
Epidemiology top 2%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies

Papers in

Hepatology 24
- Hepatitis C virus research 15
- Liver Disease and Transplantation 9
- Hepatocellular Carcinoma Treatment and Prognosis 1
Epidemiology 15
- Liver Disease Diagnosis and Treatment 14
- Hepatitis B Virus Studies 4

Co-authors: Thomas Reiberger (40 shared papers)Markus Peck‐Radosavljevic (39 shared papers)Arnulf Ferlitsch (17 shared papers)Michael Trauner (21 shared papers)Philipp Schwabl (13 shared papers)Mattias Mandorfer (13 shared papers)Birgit Heinisch (2 shared papers)Matthias Pinter (3 shared papers)
Journals: Journal of Hepatology (11 papers)Liver International (4 papers)The Journal of Infectious Diseases (3 papers)Journal of Viral Hepatitis (3 papers)PLoS ONE (3 papers)
Partner nations: Austria Germany United States

In The Last Decade

B.A. Payer

40 papers receiving 1.6k citations

Peers

Countries citing papers authored by B.A. Payer

Since Specialization

Citations

This map shows the geographic impact of B.A. Payer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.A. Payer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.A. Payer more than expected).

Fields of papers citing papers by B.A. Payer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B.A. Payer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.A. Payer. The network helps show where B.A. Payer may publish in the future.

Co-authors

The 25 scholars most cited alongside B.A. Payer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with B.A. Payer Line = papers co-authored together B.A. Payer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis Journal of Hepatology ·Thomas Reiberger, Arnulf Ferlitsch, B.A. Payer, Mattias Mandorfer, Birgit Heinisch, Hubert Hayden, Frank Lammert, Michael Trauner, Markus Peck‐Radosavljevic, Harald Vogelsang	2012	259
2	Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol Gut ·Thomas Reiberger, Gregor Ulbrich, Arnulf Ferlitsch, B.A. Payer, Philipp Schwabl, Matthias Pinter, Birgit Heinisch, Michael Trauner, Ludwig Kramer, Markus Peck‐Radosavljevic, (unknown)	2012	235
3	Von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis Hepatology ·Monika Ferlitsch, Thomas Reiberger, Matthias Hoke, Petra Salzl, Bernadette Schwengerer, G. Ulbrich, B.A. Payer, Michael Trauner, Markus Peck‐Radosavljevic, Arnulf Ferlitsch	2012	152
4	New reliability criteria for transient elastography increase the number of accurate measurements for screening of cirrhosis and portal hypertension Liver International ·Philipp Schwabl, Simona Bota, Petra Salzl, Mattias Mandorfer, B.A. Payer, Arnulf Ferlitsch, Judith Stift, Friedrich Wrba, Michael Trauner, Markus Peck‐Radosavljevic, Thomas Reiberger	2014	114
5	Noninvasive screening for liver fibrosis and portal hypertension by transient elastography—a large single center experience Wiener klinische Wochenschrift ·Thomas Reiberger, Arnulf Ferlitsch, B.A. Payer, Matthias Pinter, Philipp Schwabl, Judith Stift, Michael Trauner, Markus Peck‐Radosavljevic	2012	96
6	Non-selective β-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis Journal of Gastroenterology ·(unknown), Thomas Reiberger, Arnulf Ferlitsch, B.A. Payer, Matthias Pinter, Monika Homoncik, Markus Peck‐Radosavljevic	2011	89
7	Evaluation of Portal Hypertension and Varices by Acoustic Radiation Force Impulse Imaging of the Liver Compared to Transient Elastography and AST to Platelet Ratio Index Ultraschall in der Medizin - European Journal of Ultrasound ·Petra Salzl, Thomas Reiberger, Monika Ferlitsch, B.A. Payer, Bernadette Schwengerer, Michael Trauner, Markus Peck‐Radosavljevic, Arnulf Ferlitsch	2014	73
8	Five‐year on‐treatment efficacy of lamivudine‐, tenofovir‐ and tenofovir + emtricitabine‐based HAART in HBV–HIV‐coinfected patients Journal of Viral Hepatitis ·Lana Kosi, Thomas Reiberger, B.A. Payer, Katharina Grabmeier‐Pfistershammer, Robert Straßl, Armin Rieger, Markus Peck‐Radosavljevic	2012	52
9	Portal Pressure Predicts Outcome and Safety of Antiviral Therapy in Cirrhotic Patients With Hepatitis C Virus Infection Clinical Gastroenterology and Hepatology ·Thomas Reiberger, Karoline Rutter, Arnulf Ferlitsch, B.A. Payer, Harald Hofer, S. Beinhardt, Michael Kundi, Péter Ferenci, Alfred Gangl, Michael Trauner, Markus Peck‐Radosavljevic	2011	49
10	Austrian consensus on the definition and treatment of portal hypertension and its complications (Billroth II) Wiener klinische Wochenschrift ·(unknown), Markus Peck‐Radosavljevic, Bernhard Angermayr, Christian Datz, Arnulf Ferlitsch, Monika Ferlitsch, Valentin Fuhrmann, Michael Häfner, Ludwig Kramer, A Maieron, B.A. Payer, Thomas Reiberger, Rudolf Stauber, Rudolf Steininger, Michael Trauner, Siegfried Thurnher, Gregor Ulbrich, Wolfgang Vogel, Heinz Zoller, Ivo Graziadei	2013	45
11	Hepatitis B Surface Antigen Concentrations in Patients with HIV/HBV Co-Infection PLoS ONE ·Jerzy Jaroszewicz, Thomas Reiberger, Dirk Meyer‐Olson, Stefan Mauss, Martin Vogel, Patrick Ingiliz, B.A. Payer, Matthias Stoll, Michael P. Manns, Reinhold Schmidt, Robert Flisiak, Heiner Wedemeyer, Markus Peck‐Radosavljevic, Jürgen K. Rockstroh, Markus Cornberg	2012	42
12	Value of hepatic venous pressure gradient measurement before liver resection for hepatocellular carcinoma British journal of surgery ·Stefan Stremitzer, Dietmar Tamandl, Klaus Kaczirek, Judith Maresch, Bahadur Abbasov, B.A. Payer, Arnulf Ferlitsch, Thomas Gruenberger	2011	40
13	Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV–hepatitis C virus coinfected patients AIDS ·Mattias Mandorfer, Thomas Reiberger, B.A. Payer, Arnulf Ferlitsch, F Breitenecker, Maximilian C. Aichelburg, Barbara Obermayer‐Pietsch, Armin Rieger, Michael Trauner, Markus Peck‐Radosavljevic	2012	39
14	Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive rats Journal of Hepatology ·Philipp Schwabl, B.A. Payer, Jelena Grahovac, Sabine Klein, Thomas Horvatits, Markus Mitterhauser, Judith Stift, Yves Boucher, Jonel Trebicka, Michael Trauner, Bernhard Angermayr, Valentin Fuhrmann, Thomas Reiberger, Markus Peck‐Radosavljevic	2014	38
15	Successful HCV eradication and inhibition of HIV replication by intravenous silibinin in an HIV–HCV coinfected patient Journal of Clinical Virology ·B.A. Payer, Thomas Reiberger, Karoline Rutter, S. Beinhardt, A.F. Staettermayer, Markus Peck‐Radosavljevic, Péter Ferenci	2010	35
16	Revisiting liver disease progression in HIV/HCV‐coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3 Liver International ·Mattias Mandorfer, B.A. Payer, Philipp Schwabl, Sebastian Steiner, Arnulf Ferlitsch, Maximilian C. Aichelburg, Albert Friedrich Stättermayer, Péter Ferenci, Barbara Obermayer‐Pietsch, Katharina Grabmeier‐Pfistershammer, Michael Trauner, Markus Peck‐Radosavljevic, Thomas Reiberger	2014	31
17	Considerable Under-Treatment of Chronic HCV Infection in HIV Patients despite Acceptable Sustained Virological Response Rates in a Real-Life Setting Antiviral Therapy ·Thomas Reiberger, Martin Obermeier, B.A. Payer, Axel Baumgarten, Lutwin Weitner, A Moll, Stefan Christensen, Siegfried Köppe, Michael Kundi, Armin Rieger, Markus Peck‐Radosavljevic	2011	27
18	Health‐related quality of life and severity of fatigue in HIV/HCV co‐infected patients before, during, and after antiviral therapy with pegylated interferon plus ribavirin Liver International ·Mattias Mandorfer, B.A. Payer, Bernhard Scheiner, F Breitenecker, Maximilian C. Aichelburg, Katharina Grabmeier‐Pfistershammer, Armin Rieger, Michael Trauner, Markus Peck‐Radosavljevic, Thomas Reiberger	2013	26
19	IL28B and interferon‐gamma inducible protein 10 for prediction of rapid virologic response and sustained virologic response in HIV‐HCV‐coinfected patients European Journal of Clinical Investigation ·B.A. Payer, Thomas Reiberger, Judith H. Aberle, Péter Ferenci, Heidemarie Holzmann, Armin Rieger, Markus Peck‐Radosavljevic, (unknown)	2011	26
20	A Prospective Evaluation of Pulmonary, Systemic and Hepatic Haemodynamics in HIV–HCV-Coinfected Patients before and after Antiviral Therapy with Pegylated Interferon and Ribavirin Antiviral Therapy ·Thomas Reiberger, B.A. Payer, Arnulf Ferlitsch, Wolfgang Sieghart, F Breitenecker, Maximilian C. Aichelburg, Brigitte Schmied, Armin Rieger, Michael Trauner, Markus Peck‐Radosavljevic, (unknown)	2012	23

About B.A. Payer

B.A. Payer is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Surgery and Pathology and Forensic Medicine, having authored 42 papers that have together received 1.7k indexed citations. Recurring topics across this work include Hepatitis C virus research (15 papers), Liver Disease Diagnosis and Treatment (14 papers), Liver Disease and Transplantation (9 papers), Hepatitis B Virus Studies (4 papers), HIV/AIDS drug development and treatment (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Systemic Lupus Erythematosus Research (1 paper) and Systemic Sclerosis and Related Diseases (1 paper). The work is most often cited by research in Hepatology (1.2k citations), Epidemiology (837 citations), Pharmacology (60 citations), Surgery (218 citations) and Infectious Diseases (82 citations). B.A. Payer has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Thomas Reiberger, Markus Peck‐Radosavljevic, Arnulf Ferlitsch, Michael Trauner, Philipp Schwabl, Mattias Mandorfer, Birgit Heinisch, Matthias Pinter, Petra Salzl and Armin Rieger. Their work appears in journals such as Journal of Hepatology, Liver International, The Journal of Infectious Diseases, Journal of Viral Hepatitis and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

B.A. Payer

Impact in

Papers in i

In The Last Decade

B.A. Payer

Peers

Countries citing papers authored by B.A. Payer

Fields of papers citing papers by B.A. Payer

All Works

About B.A. Payer

Explore authors with similar magnitude of impact

Papers in